InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-33.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Milligan John C.K. IV, Chairman & CEO. Insider active across 1 company, notably TherapeuticsMD, Inc.. Cumulatively, 2 filings have been published. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
103,500 sharesCommon StockSEC:0001387131-21-005567:0
103,500 sharesCommon StockSEC:0001387131-21-005567
2 of 2 declarations
About Milligan John C.K. IV
John C.K. Milligan IV is the Secretary and Chief Executive Officer of TherapeuticsMD, Inc. He oversees the company's operations and is responsible for its strategy in the healthcare sector.
